Top Markets
Coin of the day
GreenLight Biosciences Holdings GreenLight Biosciences Holdings

GreenLight Biosciences Holdings

GRNA
Rank in Stocks #28048
GreenLight Biosciences Holdings is a biotechnology firm focused on developing... GreenLight Biosciences Holdings is a biotechnology firm focused on developing and commercializing ribonucleic acid (RNA) solutions. Its innovative products serve both the human health and agricultural industries. The company's human health portfolio includes mRNA vaccines and various therapeutic treatments, while its agricultural offerings feature RNA-based innovations designed to protect honeybees and defend crops. Established in 2008, GreenLight Biosciences Holdings is based in Medford, Massachusetts.
Share Price
$0.2995
Last synced: 2023-07-21
Market Cap
$28.87M
Change (1 day)
-0.03%
Change (1 year)
0.00%
Country
US
Trade GreenLight Biosciences Holdings (GRNA)

Category

Operating Margin for GreenLight Biosciences Holdings (GRNA)
Operating Margin as of 2026 TTM: 0.00%
According to GreenLight Biosciences Holdings latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for GreenLight Biosciences Holdings from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
-149.01% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.